SEC Form 4 · accession 0001203311-17-000094
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — Chief Technical Officer
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 7:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2017 | M | 169 | $12.00 | A | 165,075 | D | |
| Common StockF3,F1 | Nov 30, 2017 | S | 169 | $60.37 | D | 164,906 | D | |
| Common StockF1 | Nov 30, 2017 | M | 7,400 | $12.16 | A | 172,306 | D | |
| Common StockF4,F1 | Nov 30, 2017 | S | 7,400 | $59.84 | D | 164,906 | D | |
| Common StockF1 | Nov 30, 2017 | M | 2,431 | $12.16 | A | 167,337 | D | |
| Common StockF1 | Nov 30, 2017 | S | 2,431 | $60.35 | D | 164,906 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $12.00 | Nov 30, 2017 | M | 169 | D | — | Aug 27, 2020 | Common Stock | 169 | 56,498 | D |
| Non-Qualified Stock Option (right to buy)F6 | $12.16 | Nov 30, 2017 | M | 7,400 | D | — | Aug 25, 2019 | Common Stock | 7,400 | 2,431 | D |
| Non-Qualified Stock Option (right to buy)F6 | $12.16 | Nov 30, 2017 | M | 2,431 | D | — | Aug 25, 2019 | Common Stock | 2,431 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F3Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $60.35 to $60.39. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F4Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $59.34 to $60.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F5Shares vested at a rate of 25% on 8/27/2011 and monthly thereafter until all the shares were fully vested on 8/27/2014.
- F6Shares vested at a rate of 25% on 8/25/2010 and monthly thereafter until all the shares were fully vested on 8/25/2013.